Intervention Protocol

Low dose cytarabine monotherapy for myelodysplastic syndromes

  1. Kathrin Bauer1,*,
  2. Franz Hutzschenreuter1,
  3. Nicole Skoetz1,
  4. Ina Monsef1,
  5. Karl-Anton Kreuzer2,
  6. Andreas Engert1

Editorial Group: Cochrane Haematological Malignancies Group

Published Online: 7 DEC 2011

DOI: 10.1002/14651858.CD009499


How to Cite

Bauer K, Hutzschenreuter F, Skoetz N, Monsef I, Kreuzer KA, Engert A. Low dose cytarabine monotherapy for myelodysplastic syndromes (Protocol). Cochrane Database of Systematic Reviews 2011, Issue 12. Art. No.: CD009499. DOI: 10.1002/14651858.CD009499.

Author Information

  1. 1

    University Hospital of Cologne, Cochrane Haematological Malignancies Group, Department I of Internal Medicine, Cologne, Germany

  2. 2

    University Hospital of Cologne, Department I of Internal Medicine, Cologne, Germany

*Kathrin Bauer, Cochrane Haematological Malignancies Group, Department I of Internal Medicine, University Hospital of Cologne, Kerpener Str. 62, Cologne, 50924, Germany. kathrin.bauer@uk-koeln.de.

Publication History

  1. Publication Status: New
  2. Published Online: 7 DEC 2011

SEARCH

No citations currently available for this article.